Goshuyuto, Rabeprazole Shown to Treat Refractory H. pylori

This article originally appeared here.
Share this content:
<i>Goshuyuto</i>, Rabeprazole Shown to Treat Refractory <i>H. pylori</i>
Goshuyuto, Rabeprazole Shown to Treat Refractory H. pylori

TUESDAY, Sept. 5, 2017 (HealthDay News) -- Refractory Helicobacter pylori (HP) infection can be successfully treated with goshuyuto and rabeprazole, according to a case report published online Aug. 28 in the Journal of Digestive Diseases.

Yutaka Nagata, M.D., Ph.D., from Suwa Central Hospital in Nagano, Japan, and colleagues describe three cases of refractory HP infection after vonoprazan-based triple therapy.

All the cases had HP infection with chronic gastritis, and were treated with eradication therapy, according to the researchers. The patients' urea breath tests were positive after primary triplet therapy with amoxicillin, clarithromycin, and rabeprazole (case 1) or vonoprazan (case 2, 3). Their urea breath tests were still positive after subsequently receiving secondary eradication therapy with amoxicillin, metronidazole, and vonoprazan (case 1, 2) or rabeprazole (case 3). Their urea breath test became negative after Kampo eradication therapy consisting of goshuyuto 2.5 g three-times daily plus rabeprazole 10 mg twice daily for two days.

"Goshuyuto treatment is worth trying as another therapeutic option," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

WHO: Vaccine Hesitancy a Major Global Health Threat

WHO: Vaccine Hesitancy a Major Global Health Threat

Percentage of U.S. children 19 to 35 months who have not been vaccinated has quadrupled since 2001

FDA Down to 5 Weeks of Funding to Review New Drug Applications

FDA Down to 5 Weeks of Funding to ...

Agency cannot accept new fees or applications until the shutdown is over

FDA Approves First Generic Version of Epilepsy Drug Sabril

FDA Approves First Generic Version of Epilepsy Drug ...

Generic equivalents held to same vigorous manufacturing standards as brand-name drugs

is free, fast, and customized just for you!




Already a member?

Sign In Now »